We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Media and Biotech: 2 ETFs to Watch for Outsized Volume
Read MoreHide Full Article
In the last trading session, Wall Street declined as a stronger-than-expected November report on producer prices aggravated fears about the Federal Reserve’s interest rate hikes. Among the top ETFs, (SPY - Free Report) lost 0.75% and (DIA - Free Report) shed 0.91%, while (QQQ - Free Report) moved 0.64% down on the day.
Two more specialized ETFs are worth noting, as both saw trading volume that was far outside of normal. In fact, both these funds experienced volume levels that were more than double their average for the most-recent trading session. This could make these ETFs the ones to watch out for in the days ahead to see if this trend of extra interest continues.
: Volume 10.67 Times Average
This media ETF was in the spotlight as around 80,000 shares moved hands compared with an average of 9,000 shares a day. We also saw some price movement as PBS gained 0.6% in the last session.
The move was largely the result of improving consumer sentiment that would lead to higher spending and have a big impact on media ETFs like the ones we find in this ETF portfolio. PBS has climbed 2.3% over the past month and has a Zacks ETF Rank #3 (Hold) with a Medium risk outlook.
This biotech ETF was under the microscope as nearly 114,000 shares moved hands. This compared with an average trading volume of roughly 37,000 shares and came as FBT lost 1.8% in the last trading session.
The movement can largely be blamed on risk-off trading. FBT has gained 7.2% in a month and has a Zacks ETF Rank #2 (Buy) with a Medium risk outlook.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Media and Biotech: 2 ETFs to Watch for Outsized Volume
In the last trading session, Wall Street declined as a stronger-than-expected November report on producer prices aggravated fears about the Federal Reserve’s interest rate hikes. Among the top ETFs, (SPY - Free Report) lost 0.75% and (DIA - Free Report) shed 0.91%, while (QQQ - Free Report) moved 0.64% down on the day.
Two more specialized ETFs are worth noting, as both saw trading volume that was far outside of normal. In fact, both these funds experienced volume levels that were more than double their average for the most-recent trading session. This could make these ETFs the ones to watch out for in the days ahead to see if this trend of extra interest continues.
: Volume 10.67 Times Average
This media ETF was in the spotlight as around 80,000 shares moved hands compared with an average of 9,000 shares a day. We also saw some price movement as PBS gained 0.6% in the last session.
The move was largely the result of improving consumer sentiment that would lead to higher spending and have a big impact on media ETFs like the ones we find in this ETF portfolio. PBS has climbed 2.3% over the past month and has a Zacks ETF Rank #3 (Hold) with a Medium risk outlook.
(FBT - Free Report) : Volume 3.21 Times Average
This biotech ETF was under the microscope as nearly 114,000 shares moved hands. This compared with an average trading volume of roughly 37,000 shares and came as FBT lost 1.8% in the last trading session.
The movement can largely be blamed on risk-off trading. FBT has gained 7.2% in a month and has a Zacks ETF Rank #2 (Buy) with a Medium risk outlook.